Barrier Function of the GI Tract in Health and Disease
Barrier Function of the GI Tract in Health and Disease
批准号:
8337712
负责人:
W ALLAN WALKER
金额:
$140.24万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2016-08-31
关键词:
AcuteAffectBacteriaBacterial ToxinsCell CommunicationCellsColitisCommunicable DiseasesCorticotropin-Releasing HormoneDevelopmentDevelopmental BiologyDiarrheaDisciplineDiseaseEnteralEnterocytesEnterotoxinsEpithelialEpithelial CellsFamilyGastrointestinal tract structureGeneral HospitalsGenesGuanine Nucleotide Exchange FactorsHealthHost DefenseHumanHydrocortisoneImageImmuneImmunityInfectionInflammationInflammatoryInflammatory disease of the intestineIntestinal DiseasesIntestinesLaboratoriesLeadLocationLymphoidMassachusettsMediatingMicrobiologyMolecularMolecular BiologyMucositisNerveNeuropeptide ReceptorNeuropeptidesPathogenesisPathway interactionsPenetrationPlayPreventionPrevention strategyProbioticsResearch PersonnelRoleShigella flexneriSiteStimulusTestingTherapeutic EffectTissuesToxinTranslationsTransplantationXenograft procedureapical membranebasolateral membraneenteric pathogenfetalinterdisciplinary approachmicrobialnovel therapeuticspathogenprematurepreventprogramsprotective effectreceptorreceptor expressionresponserho
中文摘要
该计划项目更新申请继续关注肠上皮细胞在以下方面的作用:
在微生物和肠毒素介导的刺激与免疫之间的界面处的粘膜屏障功能
效应子反应肠上皮细胞是中心焦点,将研究微生物的“串扰”。
免疫-上皮细胞相互作用、神经肽受体表达、不适当的发育
反应,以及微生物渗透的屏障。此更新应用程序包括五个交互式
由两个核心支持的项目,(1)行政和(2)异种移植/同种移植,人类
肠组织和成像核心主要在一个位置的粘液免疫实验室,
马萨诸塞州东总医院(BIdg 114)。项目1将检查NF kappaB/MyD88中的未成熟度
先天反应基因和其他炎症途径在胎儿与成熟肠上皮细胞,以帮助解释
早产儿肠道过度炎症和氢化可的松测试成熟预防,
益生菌项目2将研究参与促肾上腺皮质激素释放的机制。
激素家族神经肽及其受体在粘膜炎症发生中的作用
对肠毒素和细菌病原体的反应。项目3将研究
S.福氏肠上皮细胞在顶端或基底外侧膜域的相互作用,导致急性
传染性结肠炎项目4将确定GEF-H1(一种鸟嘌呤核苷酸交换因子)的作用
对于Rho,上皮细胞对病原体的反应,并检查这种反应的机制,
交界水平。项目5将定义参与保护性免疫的特定细胞和分子机制。
和益生菌剂布拉酵母菌在肠道感染和肠毒素介导的
腹泻和尿道炎。细胞/分子生物学、微生物学、
肠免疫和炎症。cand发育生物学将提供一个更好的理解,
细菌GI感染和肠毒素介导的肠道炎症的发病机制,
预防和治疗胃肠道感染性疾病的新治疗策略。
英文摘要
This Program Project renewal application continues to have a narrow focus on the role of enterocytes in
mucosal barrier function at the interface between microbial and enterotoxin-mediated stimuli and immune
effector responses. The enterocyte is the central focus and will be studied with regard to microbial "crosstalk"
and immune-epithelial cell interactions, neuropeptide receptor expression, inappropriate developmental
responses, and a barrier to microbial penetration. This renewal application consists of five interactive
projects supported by two cores, (1) An Administrative and (2) a Xenograft/lsograft Transplant, human
intestinal tissue and imaging core principally in one location in the Mucosal Immunolog Laboratory at the
Massachusetts General Hospital-East (BIdg 114). Project 1 will examine immaturities in NFkappaB/MyD88
innate response genes and in other inflammatory pathways in fetal vs. mature enterocytes to help explain
excessive intestinal inflammation in prematures and test maturational prevention with hydrocortisone and
probiotics. Project 2 will examine the mechanisms involved in the participation of corticotropin-releasing
hormone family of neuropeptides and their receptors in the development of mucosal inflammation in
response to enterotoxiris and bacterial pathogens. Project 3 will study the molecular mechanisms underiying
S. flexneri-intestinal epithelial interactions at the apical or basolateral membrane domain that lead to acute
infectious colitis. Project 4 will determinethe role of GEF-H1, a guanine nucleotide exchange factor (GEF)
for Rho, on epithelial cell responses to pathogens and examine the mechanism of this response at the tight
junctional level. Project 5 will define specific cellular and molecularmechanisms involved in the protective
and therapeutic effects of the probiotic agent .S.boulardii in enteric infections and enterotoxin-mediated
diarrhea and intestinal.inflammation. Investigators.with disciplines in cell/molecular biology,,microbiology,
intestinal immunity and inflammation.cand developmental biology will provide a better understanding of the
pathogenesis of bacterial Gl infections and enterotoxin-mediated intestinal inflammation and niay lead to
new therapeutic strategies in preventing and treating infectious diseases in the Gl tract.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FASEB SRC on Probiotics, Intestinal Microbiota and the Host: Physiological and Cl
-
批准号:8200047
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:W ALLAN WALKER
-
依托单位:
Barrier Function of the GI Tract in Health and Disease
-
批准号:8013264
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2010
-
负责人:W ALLAN WALKER
-
依托单位:
Harvard Clinical Nutrition Research Center
-
批准号:8011157
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2010
-
负责人:W ALLAN WALKER
-
依托单位:
Maturation of intestinal innate immunity and NEC
-
批准号:8220976
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2009
-
负责人:W ALLAN WALKER
-
依托单位:
Maturation of intestinal innate immunity and NEC
-
批准号:8440837
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2009
-
负责人:W ALLAN WALKER
-
依托单位:
Barrier Function of the GI Tract in Health and Disease
-
批准号:7868666
-
项目类别:
-
资助金额:$8.42万
-
财政年份:2009
-
负责人:W ALLAN WALKER
-
依托单位:
BACTERIAL EPITHELIAL CROSSTALK IN DEVELOPING INTESTINE
-
批准号:7487450
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2007
-
负责人:W ALLAN WALKER
-
依托单位:
Pilot and Feasibility
-
批准号:7504414
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2007
-
负责人:W ALLAN WALKER
-
依托单位:
Administrative Core
-
批准号:7499795
-
项目类别:
-
资助金额:$27.82万
-
财政年份:2007
-
负责人:W ALLAN WALKER
-
依托单位:
TISSUE CULTURE MORPHOLOGY TRANSPLANT MODEL
-
批准号:7487455
-
项目类别:
-
资助金额:$45.72万
-
财政年份:2007
-
负责人:W ALLAN WALKER
-
依托单位:
Barrier Function of the Gi Tract in Health and Disease
-
批准号:7499906
-
项目类别:
-
资助金额:$35.54万
-
财政年份:2007
-
负责人:W ALLAN WALKER
-
依托单位:
IMMUNOLOGY CORE
-
批准号:7002019
-
项目类别:
-
资助金额:$13.71万
-
财政年份:2006
-
负责人:W ALLAN WALKER
-
依托单位:
Administrative Core A
-
批准号:7116039
-
项目类别:
-
资助金额:$42.62万
-
财政年份:2006
-
负责人:W ALLAN WALKER
-
依托单位:
TISSUE CULTURE MORPHOLOGY TRANSPLANT MODEL
-
批准号:7022019
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2005
-
负责人:W ALLAN WALKER
-
依托单位:
BACTERIAL EPITHELIAL CROSSTALK IN DEVELOPING INTESTINE
-
批准号:7021996
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2005
-
负责人:W ALLAN WALKER
-
依托单位:
BACTERIAL TOXINS INTERACTION WITH THE GUT
-
批准号:6653313
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2002
-
负责人:W ALLAN WALKER
-
依托单位:
BACTERIAL TOXINS INTERACTION WITH THE GUT
-
批准号:6496932
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2001
-
负责人:W ALLAN WALKER
-
依托单位:
TEACHING NUTRITION TO PREVENT CARDIOVASCULAR DISEASES
-
批准号:6088583
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2000
-
负责人:W ALLAN WALKER
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6316607
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2000
-
负责人:W ALLAN WALKER
-
依托单位:
TEACHING NUTRITION TO PREVENT CARDIOVASCULAR DISEASES
-
批准号:6380210
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2000
-
负责人:W ALLAN WALKER
-
依托单位:
海外基金